A cultured living bone equivalent enhances bone formation when compared to a cell seeding approach

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Surgery

Background:

• Cell therapy is increasingly used to enhance the osteogenic potential of synthetic bone graft materials.
• Two main approaches involve seeding scaffolds with patient-derived osteogenic cells for bone tissue engineering.
• These methods aim to create autologous osteogenic grafts for improved bone regeneration.

Purpose of the Study:

• To compare the in vivo osteogenic potential of two cell-based bone tissue engineering strategies.
• To evaluate the efficacy of pre-formed in vitro bone-like tissue on hydroxyapatite scaffolds versus cell-seeded scaffolds.

Main Methods:

• Porous hydroxyapatite (HA) scaffolds were prepared using two methods: seeding with osteogenic cells or coating with in vitro formed bone.
• Scaffolds were implanted in vivo to assess their osteogenic capacity.
• Histological analysis and quantitative bone assessment were performed at early time points post-implantation.

Main Results:

• De novo bone tissue formation was observed as early as 2 days post-implantation in scaffolds with pre-formed in vitro bone.
• In contrast, bone formation was detected from 4 days onwards in cell-seeded scaffolds.
• Significantly higher bone volume was found in the in vitro bone-like tissue scaffolds compared to cell-seeded scaffolds after 4 days.

Conclusions:

• Pre-culturing scaffolds with in vitro bone-like tissue accelerates new bone formation in vivo.
• This approach demonstrates superior osteogenic potential compared to traditional cell-seeding methods for bone tissue engineering.
• The findings suggest that pre-formed bone matrix enhances the integration and regenerative capacity of synthetic bone grafts.